GPT and COVID-19: Current recommendations from the gastroenterology and hepatology societies endorse a thorough evaluation and monitoring for alternative causes of elevated liver enzymes in COVID-19 patients.39 40 This was based on a metanalysis of 47 studies, analysing over 10 000 patients with COVID-19, showing a pooled prevalence of elevated AST of 15.0% and alanine transaminase of 15.0%, underlining the importance of comprehensive assessment and monitoring.39